Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 3Completed 3Recruiting 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Colonic Neoplasms 2Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Capecitabine 29Oxaliplatin 28Fluorouracil 16Radiotherapy 15Drug Therapy 11Leucovorin 10Bevacizumab 10Surgical Procedures, Operative 9Chemoradiotherapy 8Radiation 7sintilimab 6Consolidation Chemotherapy 6tislelizumab 5spartalizumab 5XELOX 5Specimen Handling 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4Neoadjuvant Therapy 4Endoscopy 4Cetuximab 4Biopsy 4toripalimab 3pembrolizumab 3irinotecan sucrosofate 3X-Rays 3Radiotherapy, Intensity-Modulated 3Proctectomy 3Mastectomy, Segmental 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Rectal Neoplasms × FOLFOXIRI protocol × Clear all
NCT05201430 2022-03-04

RCNAC

Fudan University

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03671252 2019-01-23

Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation

Sun Yat-sen University

Phase 3 Recruiting
776 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡